In this study, 67 sporadic CRC and eight samples of normal bowel were analysed for MSI status (by SSCP) and levels of MLH1, MSH2 and p53 gene transcription (by RT–PCR and scanning densitometry). The gene discussed is TP53; the disease is colorectal carcinoma.